Announcement • Apr 16
Moolec Science SA, Annual General Meeting, May 13, 2026 Moolec Science SA, Annual General Meeting, May 13, 2026. Announcement • Feb 27
Moolec Science SA Announces Board and Committee Changes, Effective February 25, 2025 Moolec Science SA announced changes to the composition of its Board of Directors. Daniel Core has been appointed to the Company's Board of Directors, effective February 25, 2025. Mr. Core has also been appointed as a member of the Audit Committee and the Compensation Committee of the Board. Daniel Core is a U.S.-based quality and operations professional with more than three decades of experience in industrial manufacturing environments. His background includes quality leadership roles across multinational and precision manufacturing organizations, with a focus on operational discipline, compliance, and process integrity. Mr. Core has held quality assurance and quality leadership positions with organizations including Illinois Tool Works, MW Components, Aptix, and Stanley Black & Decker. His experience spans the implementation and oversight of established quality management systems and regulatory frameworks commonly applied in regulated manufacturing sectors. He has extensive experience supporting internal and external audit processes, strengthening quality systems, and contributing to continuous improvement initiatives focused on risk reduction, cost discipline, and operational efficiency. Mr. Core currently serves in a quality leadership role within the manufacturing sector in New England. He brings a disciplined, systems-oriented perspective to Board discussions, informed by hands-on experience with quality governance, compliance environments, and operational risk management. Aimar Dimo and Gloria Montaron Estrada have each resigned from the Company's Board of Directors, effective February 25, 2025. Announcement • Nov 23
Moolec Receives Nasdaq Determination Letter Moolec Science SA announced that it received a determination letter (the "Nasdaq Determination Letter") from the Nasdaq Stock Market LLC ("Nasdaq") indicating that the closingbid price of the Company's ordinary shares had been below the minimum $1.00 per share requirement for the last 30 consecutive business days, as set in Nasdaq Listing Rule 5550(a)(2), and informing the Company of their view that the Company would not be afforded an automatic 180-day period to regain compliance with such rule. The Company has submitted a timely appeal to a Nasdaq Hearings Panel, through which it will request the granting of a 180- day period to submit and effect a compliance plan, which will include a potential implementation of a reverse stock split, if determined to be in the best interest of shareholders. The submission of the appeal automatically stays the effect of the Nasdaq Determination Letter until the appeal has been considered, which will take place on December 18, 2025. Accordingly, the Company's ordinary shares will continue to trade on The Nasdaq Capital Market under the symbol "MLEC" without interruption during such stay. The Company intends to continue closely monitoring the closingbid price for its ordinary shares and remains committed to evaluating and executing all appropriate actions to cure the deficiency and regain compliance with Nasdaq Listing Rule 5550(a)(2). The receipt of the Nasdaq Determination Letter does not affect the Company's business, operations or reporting requirements with the Securities and Exchange Commission. 
